LMP1 expression can be reactivated (in the absence of concomitant EBNA2 expression) in EBV+ BL cell lines by treatment with IL21, an effect potentially mediated by STAT3 activation [34–36]. The gene discussed is PDLIM7; the disease is Burkitt lymphoma.